Filing Details

Accession Number:
0001053310-12-000001
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-06-29 18:32:37
Reporting Period:
2012-06-27
Filing Date:
2012-06-29
Accepted Time:
2012-06-29 18:32:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1016504 Integrated Biopharma Inc INBP.OB Pharmaceutical Preparations (2834) 222407475
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1053310 Gerald E Kay 225 Long Avenue
Hillside NJ 07205
Ceo And President Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-06-27 250,000 $0.09 5,270,444 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Shares disposed of in connection with a refinancing transaction involving the issuer. The Reporting Person has no preset intent to dispose of additional shares.
  2. Includes (i) 819,629 shares of common stock held by EGK LLC, of which the Reporting Person is the manager; and (ii) 307,888 shares of common stock issuable upon exercise of presently exercisable stock options; the Reporting Person shares dispositive power with Christina Kay with respect to 169,358 shares of common stock and with Riva Sheppard with respect to 169,358 shares of common stock.